[ad_1] The Alzheimer’s Foundation of America is holding its Alzheimer’s Walk in the Park to raise awareness and funds for families affected by the disease. The walk is set for…
Tag: Alzheimers
How a Swedish start-up reignited the search for an Alzheimer’s drug
[ad_1] Gunilla Osswald speaks quietly as she describes her last act at AstraZeneca. After 28 years of trying to create treatments for patients with brain disorders, in 2012 she was…
Alzheimer’s Blockbuster Is Coming, but Slowly
[ad_1] Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. [ad_2] Source link
Medicare plans to pay for Alzheimer’s drugs that win full FDA approval
[ad_1] The Centers for Medicare & Medicaid Services said Thursday that it will pay for new Alzheimer’s drugs that are granted full approval from the Food and Drug Administration, although…
Medicare Plans to Cover Alzheimer’s Drugs
[ad_1] Biogen and Eisai’s Leqembi is up for full approval this summer. [ad_2] Source link
Access to New Alzheimer’s Drugs Might Depend on Where You Live
[ad_1] Big clinics are giving Leqembi to some patients while rural providers said they would wait. [ad_2] Source link
Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business
[ad_1] What’s the future of Alzheimer’s disease treatment? How do you pivot from a pandemic? And how successful can Wegovy get? We cover all that and more this week on…
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
[ad_1] The Alzheimer’s treatment donanemab, which is made by Eli Lilly, significantly slowed progression of the mind-robbing disease, according to clinical trial data released Wednesday by the company. Patients who…
New Alzheimer’s drug slows disease by a third – BBC News
[ad_1] By James Gallagher Health and science correspondent 8 hours ago Image source, Getty Images We could be entering the era of Alzheimer’s treatments, after the second drug in under…
Bipartisan attorneys general call on Medicare to cover Alzheimer’s treatments
[ad_1] Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatments for Alzheimer’s disease, according to a letter…